---
title: "12 Health Care Stocks Moving In Tuesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279492684.md"
description: "In Tuesday's after-market session, several health care stocks experienced notable movements. Bio Green Med Solution (BGMSP) rose 10.9% to $3.15, while bioAffinity Technologies (BIAF) increased by 10.58% to $3.03. High Tide (HITI) shares climbed 7.63% to $2.68, and Apimeds Pharmaceuticals (APUS) saw a 7.22% rise to $1.78. Conversely, Sharps Technology (STSS) fell 10.9% to $1.71, and Lunai Bioworks (LNAI) dropped 10.44% to $0.5. Other notable losers included Akari Therapeutics (AKTX) and Scienture Holdings (SCNX)."
datetime: "2026-03-17T21:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279492684.md)
  - [en](https://longbridge.com/en/news/279492684.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279492684.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's After-Market Session

### Gainers

-   **Bio Green Med Solution** (NASDAQ:BGMSP) stock moved upwards by 10.9% to $3.15 during Tuesday's after-market session.
-   **bioAffinity Technologies** (NASDAQ:BIAF) shares rose 10.58% to $3.03. The company's market cap stands at $8.5 million. The company's, Q4 earnings came out 2 days ago.
-   **High Tide** (NASDAQ:HITI) shares increased by 7.63% to $2.68. The market value of their outstanding shares is at $218.7 million. As per the press release, Q1 earnings came out today.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) stock increased by 7.22% to $1.78. The company's market cap stands at $20.6 million.
-   **GridAI Technologies** (NASDAQ:GRDX) stock increased by 6.88% to $2.33. The company's market cap stands at $8.0 million.
-   **Dare Bioscience** (NASDAQ:DARE) shares rose 6.08% to $1.54. The market value of their outstanding shares is at $21.0 million.

### Losers

-   **Sharps Technology** (NASDAQ:STSS) stock declined by 10.9% to $1.71 during Tuesday's after-market session. The market value of their outstanding shares is at $56.8 million.
-   **Lunai Bioworks** (NASDAQ:LNAI) shares decreased by 10.44% to $0.5. The market value of their outstanding shares is at $5.1 million.
-   **Akari Therapeutics** (NASDAQ:AKTX) stock fell 9.68% to $0.2. The market value of their outstanding shares is at $7.3 million.
-   **Scienture Holdings** (NASDAQ:SCNX) shares fell 8.7% to $0.44. The company's market cap stands at $18.4 million.
-   **Longeveron** (NASDAQ:LGVN) shares decreased by 7.32% to $0.89. The market value of their outstanding shares is at $18.9 million. As per the news, the Q4 earnings report came out today.
-   **Kestra Medical Techs** (NASDAQ:KMTS) stock fell 7.01% to $19.66. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [STSS.US](https://longbridge.com/en/quote/STSS.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BGMS.US](https://longbridge.com/en/quote/BGMS.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [HITI.US](https://longbridge.com/en/quote/HITI.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [SKYA.US](https://longbridge.com/en/quote/SKYA.US.md)

## Related News & Research

- [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md)
- [Apimeds Pharmaceuticals US gains Apitox rights in assignment from South Korea’s FreeT](https://longbridge.com/en/news/296653985.md)
- [bioAffinity signs AvMEDICAL distribution deal for CyPath Lung in federal healthcare market](https://longbridge.com/en/news/296224749.md)
- [High Tide holds annual shareholder meeting](https://longbridge.com/en/news/295645855.md)
- [High Tide to Announce Second Fiscal Quarter 2026 Financial Results | HITI Stock News](https://longbridge.com/en/news/288554265.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**